Solutions
Neurosurgeon operating with intraoperative brain imaging
Neurosurgery
Functional brain-network data for complex neurosurgical decisions.
Clinician reviewing brain imaging on a monitor
Neurology
Objective brain function insights for more informed neurological care.
Older couple walking outdoors
Brain Health
Supporting healthier brains through earlier insight.
Clinicians reviewing a brain scan on a monitor
Clinical Research
Empowering the next generation of neuroscience research.
TechnologyResourcesQuantalX NeuroscienceReimbursementAboutContact us
QuantalX Neuroscience
All resources
Peer-reviewed publication
npj Parkinson's Disease
2024

TMS-evoked potentials unveil occipital network involvement in patients diagnosed with Parkinson's disease within 5 years of inclusion

Zifman N, Levy-Lamdan O, Hiller T, Thaler A, Dolev I, Mirelman A, Fogel H, Hallett M, Maidan I

npj Parkinson's Disease journal cover
Key finding

Occipital TMS-evoked potential measures identified patients with rapid disease progression with 85% accuracy, pointing to occipital network involvement in early Parkinson's disease.

Study design
Case-control study, TMS-EEG
Participants
62 patients with Parkinson's disease and 76 healthy controls

Summary

This study looked at whether network responses to magnetic stimulation can help distinguish subgroups of patients with Parkinson's disease (PD). TMS-evoked potentials (TEPs) from three brain networks were compared between patients diagnosed within the previous five years and healthy controls of similar age.

Study design

  • Participants: 62 patients with PD (age 69.9 ± 7.5) and 76 healthy controls (age 69.2 ± 4.3).
  • Stimulation sites: bilateral primary motor cortex (M1), dorsolateral prefrontal cortex (DLPFC) and visual cortex (V1).
  • Patients were divided into tremor-dominant (TD), non-tremor-dominant (NTD) and rapid disease progression (RDP) subgroups.
  • Analysis: two-way ANCOVA adjusted for MoCA score.

Key findings

  • Patients with PD showed lower wide-waveform adherence (p = 0.025) and lower interhemispheric connectivity (p < 0.001) than healthy controls.
  • Lower occipital interhemispheric connectivity correlated with a more advanced disease stage (r = −0.37, p = 0.0039).
  • The RDP and NTD subgroups showed lower wide-waveform adherence in response to occipital stimulation than the TD subgroup (p = 0.005).
  • Occipital TEP measures identified RDP patients with 85% accuracy.

Authors' conclusions

The authors conclude that the findings show occipital network involvement in early stages of PD and suggest that TEP measures may offer insight into the altered networks of PD subgroups.

Read the full article

Zifman N, Levy-Lamdan O, Hiller T, Thaler A, Dolev I, Mirelman A, Fogel H, Hallett M, Maidan I. TMS-evoked potentials unveil occipital network involvement in patients diagnosed with Parkinson's disease within 5 years of inclusion. npj Parkinson's Disease. 2024;10:182. doi:10.1038/s41531-024-00793-0

Summary prepared by QuantalX from the published abstract. All results are as reported by the authors. The full text is available from the publisher.

Bring brain function data into your practice

Talk to the QuantalX team about Delphi-MD™ in your clinical setting.

Request a demo
On this page
Section
Journal
npj Parkinson's Disease
Year
2024
DOI
10.1038/s41531-024-00793-0
Licence
Open access, CC BY-NC-ND 4.0. Summary by QuantalX
Read in the journal
QuantalX Neuroscience
Join our newsletter to stay up to date on clinical updates and company news.
By subscribing you agree to our Privacy Policy and provide consent to receive updates from our company.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Solutions
NeurosurgeryNeurologyBrain HealthClinical ResearchPsychiatry
Company
TechnologyPartner ZoneResourcesAbout UsContact
Follow us
Facebook
Instagram
X
LinkedIn
© 2026 Quantalx. All rights reserved.
Privacy PolicyTerms of Service
*All clinical interpretations of Delphi-MD™ assessments must be made by qualified healthcare professionals within the context of a full patient evaluation. The Delphi-MD™ system is intended to elicit, record, and analyze TMS-evoked brain potentials (TEPs) and provide quantitative output parameters compared against a normative reference database limited to ages 50–75. Adverse events during or after evaluation may include headache, nausea, dizziness, fatigue, insomnia, anxiety/agitation, back or neck pain, vomiting, tinnitus, migraine aura, and abnormal sensations. Delphi-MD™ is not intended to be relied upon solely to make or confirm a diagnosis. For more information, refer to the Delphi-MD™ user manual.
Schedule a Demo